U.S. flag

An official website of the United States government

NM_000071.3(CBS):c.5C>T (p.Pro2Leu) AND HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 31, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002517994.9

Allele description [Variation Report for NM_000071.3(CBS):c.5C>T (p.Pro2Leu)]

NM_000071.3(CBS):c.5C>T (p.Pro2Leu)

Gene:
CBS:cystathionine beta-synthase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
21q22.3
Genomic location:
Preferred name:
NM_000071.3(CBS):c.5C>T (p.Pro2Leu)
Other names:
p.P2L:CCT>CTT
HGVS:
  • NC_000021.9:g.43072189G>A
  • NG_008938.1:g.8742C>T
  • NM_000071.3:c.5C>TMANE SELECT
  • NM_001178008.3:c.5C>T
  • NM_001178009.3:c.5C>T
  • NM_001320298.2:c.5C>T
  • NP_000062.1:p.Pro2Leu
  • NP_000062.1:p.Pro2Leu
  • NP_001171479.1:p.Pro2Leu
  • NP_001171480.1:p.Pro2Leu
  • NP_001307227.1:p.Pro2Leu
  • LRG_777t1:c.5C>T
  • LRG_777:g.8742C>T
  • LRG_777p1:p.Pro2Leu
  • NC_000021.8:g.44492299G>A
  • NM_000071.2:c.5C>T
Protein change:
P2L
Links:
dbSNP: rs546530618
NCBI 1000 Genomes Browser:
rs546530618
Molecular consequence:
  • NM_000071.3:c.5C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001178008.3:c.5C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001178009.3:c.5C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001320298.2:c.5C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED
Identifiers:
MedGen: C3150344

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV001414142Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))		Uncertain significance
(Aug 31, 2021) 		germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001414142.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces proline with leucine at codon 2 of the CBS protein (p.Pro2Leu). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs546530618, ExAC 0.04%). This variant has not been reported in the literature in individuals affected with CBS-related conditions. ClinVar contains an entry for this variant (Variation ID: 212839). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024